Healthcare supply chains in the U.S. faced big challenges because of the sudden rise in demand for important items like personal protective equipment (PPE), medicines, and vaccines. There were also delays in shipping. Many providers depended on just a few suppliers. There was little information about what was happening in the supply chain, making quick action hard.
Research from McKinsey shows healthcare was one of the first sectors to take steps to make supply chains stronger during the pandemic. About 60% of healthcare groups moved some supply chain operations closer to their regions. Also, 33% brought production nearer to the places where products are used. These moves helped cut down problems caused by relying on faraway suppliers.
Still, problems remain. McKinsey says fewer than half of companies, including healthcare ones, fully understand risks beyond their top-level suppliers. Only 2% know what is happening with suppliers further down the chain. When these hidden suppliers face problems, it can cause shortages or delays without warning.
The pandemic showed three main problems in healthcare supply chains:
These problems led to shortages and delays, which hurt patient care and how well operations ran.
One key lesson from COVID-19 is to change from ‘just in time’ to ‘just in case’ in managing supplies. This means healthcare providers should keep extra amounts of important items to handle sudden needs or supply shocks.
The Access to Medicine Foundation points out that holding extra stockpiles is a main way to make supply chains stronger. Having backup supplies can lessen the effect of supplier problems and shipping delays. While keeping more inventory may cost a bit more, it helps keep supplies steady and patients safer.
Medical administrators should work with procurement teams to study usage patterns and find the right balance between cost and safety by keeping needed supplies on hand.
Using more suppliers is another key way to reduce risks in supply chains. Depending on just a few suppliers leaves organizations open to big problems if those suppliers stop working. Having suppliers from different places, including local and international manufacturers, helps keep supplies steady during local troubles.
In the U.S., working with big drug companies and local makers can boost local production of needed medicines. This helps cut down dependence on suppliers from other countries. These choices follow the trend toward bringing supply chains closer to home seen during the pandemic.
Changing buying policies to include more suppliers encourages competition and stronger suppliers. Medical practice owners should check contracts and vendor relationships to find chances to add more suppliers.
After the pandemic, 95% of companies, including those in healthcare, have formal risk management. But many still find it hard to spot risks beyond their main suppliers. The pandemic showed that problems can happen deep in the supply chain without being noticed quickly.
Healthcare leaders and IT managers should focus on technologies that give better views of the whole supply chain and allow real-time tracking. Tools that combine data from many suppliers, shipping firms, and warehouses can find hidden weaknesses. Ongoing risk checks and good communication with suppliers can help stop supply problems before they become serious.
Working closely with suppliers, healthcare providers, and governments is important to share information fast and act together in emergencies.
McKinsey’s studies show that companies with strong data analytics handled supply chain disruptions better during the pandemic. These organizations were 2.5 times more likely to plan well and adjust quickly.
Advanced analytics support healthcare by:
Healthcare IT managers should focus on getting analytics platforms that work with supply chain systems. They should also train or hire staff with skills in data science to help these efforts succeed.
Even with progress, healthcare supply chains use fewer advanced digital tools than other industries. McKinsey’s report says only 1% of companies feel they have enough in-house digital experts now, down from 10% in 2020. This shortage makes it hard to fully use new technology solutions.
To fix this, healthcare groups must invest in training to teach current workers new skills. They should also hire experts from outside and use consultants experienced in digital supply chain work.
During the pandemic, many healthcare places increased their inventory to manage supply risks faster. Growing manufacturing or suppliers takes time, but adding stock can be done quickly.
Keeping larger stocks needs more storage and money, but it provides a safety buffer. Medical administrators should look at how fast critical supplies are used and keep enough stock to keep patient care steady even during supply problems.
Artificial Intelligence (AI) and workflow automation can help make healthcare supply chains work better. These tools help with daily operations in many ways:
Practice owners and IT managers should add AI tools to current supply systems. This will make buying smoother, reduce paperwork, and make supplies more reliable. AI also helps shift toward fixing problems before they happen.
The pandemic showed benefits of making products closer to the users. Moving production near the consumers helps reduce waiting times and respond better to demand spikes.
McKinsey says nearly 90% of companies plan to keep regionalization efforts. In healthcare, 60% already made moves to produce or source locally.
Regionalization also helps protect the country by lowering dependence on suppliers far away, especially during political or global crises.
Healthcare managers should form partnerships with local manufacturers and distributors. They should also support policies that build domestic production of key healthcare supplies.
Making healthcare supply chains stronger needs teamwork between government, healthcare organizations, manufacturers, and buyers. The Access to Medicine Foundation points out that future readiness depends on shared work and well-coordinated efforts.
Good communication and data sharing between companies and public health groups help spot risks and move resources fast. Government programs and easier rules can encourage local making and supplier diversity.
Healthcare leaders should work closely with local health offices, regional groups, and industry associations. This helps them stay updated on best practices and join group readiness plans.
By following these steps, healthcare providers in the U.S. can build stronger supply chains. This helps make sure patient care keeps going even during hard times. The COVID-19 pandemic showed these lessons clearly, and it is important to act on them now.
The pandemic highlighted vulnerabilities such as shortages, stockouts, sudden demand spikes, and disruptions to shipping. An over-reliance on a small number of suppliers, often concentrated in one region, was identified as a significant risk.
A transition from a ‘just in time’ to a ‘just in case’ model is crucial to ensure continuous delivery of critical medicines and vaccines, especially in response to potential disruptions.
1. Prioritize global health security in decision-making. 2. Widen and strengthen the supplier base. 3. Identify and fix the weakest links in access to medicine.
Changes in procurement policies should focus on ensuring continuity of supply by diversifying the supplier base and considering a wider range of suppliers in tender processes.
Technology can enhance smart forecasting, demand planning, and facilitate better communication between suppliers and procurers, improving the resilience of supply chains.
A diverse supplier base reduces dependency on single sources, mitigating risks of shortages. This expands access to essential medicines and ensures greater supply chain robustness.
Collaboration between multinational corporations and local manufacturers, along with technology transfers and capacity building, can enhance local production and availability of essential medicines.
The industry faced interconnections issues, sudden disruptions, and specific regional vulnerabilities that affected access to medicines, vaccines, and healthcare products.
The goal is to stimulate good practices and address vulnerabilities in the global supply of essential medicines and vaccines, by bringing various essential healthcare stakeholders together.
The Foundation plans to engage with companies, governments, and procurers to adopt best practices, and will expand its focus to key sectors like generic medicines, vaccines, and diagnostics.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
